Open official notice

Losartan Potassium Tablets, USP 50 mg 1000 film coated tablets Rx Only

Official notice

29 May 2019

RecallScope risk estimate:MediumFDA

An official FDA notice concerns Losartan Potassium Tablets, USP 50 mg 1000 film coated tablets Rx Only. CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer Published 2019-05-29.

What to do now

This recall has been terminated. See the official FDA notice for the latest status.

Units affected

3,012

Recall number

D-1287-2019

Official notice

2019-05-29

The hazard

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Lots

CLO17007A, CLO17008A, CLO17009A

Event Ids

82782

Recall Numbers

D-1287-2019

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Losartan Potassium Tablets, USP 50 mg 1000 film coated tablets Rx Only Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108 SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India. Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816. 1-866-901-DRUG (3784) NDC 23155-645-10

Units affected

3,012

Hazard

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Manufacturer

Heritage Pharmaceuticals, Inc.

Phone

Not provided

Brand: Heritage Pharmaceuticals. Contact: Heritage Pharmaceuticals, Inc..

Source & status

Source

Tier

official

Category

Health

Official classification

Class II

Recall details

Recall number

D-1287-2019

Event ID

82782

Units affected

3,012

Status

terminated

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 29 May 2019. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button